“…Copper(II) complexes can identify DNA via non-covalent binding modes such as intercalation, groove, and external electrostatic contacts, leading to significant distortion in its structure and the proper biological function [20,21]. Intercalative binding, which is facilitated through welltailored aromatic structures able to stabilize the π-π interactions, is considered to be the most effective mode for DNA targeting drugs [22,23]. At the same time, in copper(II) complexes, the number of single ligands acts in a bidentate manner in combination with a fourth monodentate labile one, which enables the complex to covalently bind with the nucleobases or the phosphate backbone or other interactions with cellular targets, thereby exerting their cytotoxicity [24,25].…”